Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Katia Marzo"'
Autor:
Laura Evangelista, Priscilla Guglielmo, Giulia Giacoppo, Lucia Setti, Demetrio Aricò, Lorenzo Muraglia, Katia Marzo, Nicolò Buffi, Vittorio Fasulo, Marcello Rodari, Jelena Jandric, Antonio Salvaggio, Manuela Bonacina, Massimo Lazzeri, Giovanni Lughezzani
Publikováno v:
Diagnostics, Vol 14, Iss 23, p 2751 (2024)
Objectives. The aim of the present study was to assess the performance of radiolabeled-PSMA PET/CT in a cohort of intermediate-risk prostate cancer (PCa) patients for initial staging. Methods. This is a retrospective, multicenter analysis of patients
Externí odkaz:
https://doaj.org/article/74ecf3a734524fe282d989424ff5b2ca
Autor:
Egesta Lopci, Massimo Lazzeri, Piergiuseppe Colombo, Paolo Casale, Nicolo M. Buffi, Alberto Saita, Roberto Peschechera, Rodolfo Hurle, Katia Marzo, Lorenzo Leonardi, Emanuela Morenghi, Luca Balzarini, Luca Disconzi, Giorgio Guazzoni, Arturo Chiti, Giovanni Lughezzani
Publikováno v:
Urologia Internationalis. :1-7
Background: This prospective single-arm study is designed to compare in parallel 68Ga-PSMA PET/TRUS (transrectal or transperineal) fusion biopsy (“experimental test”) with multiparametric MRI (mpMRI)/TRUS fusion prostate biopsy (“standard test
Publikováno v:
Rendiconti Lincei. Scienze Fisiche e Naturali. 31:231-247
Cancer is the second cause of death and morbidity in Europe. Unfortunately, currently available treatments cannot permanently cure most cancers, especially when metastatic. New therapy approaches are, therefore, urgently needed. Radionuclide therapy
Autor:
Rodolfo Hurle, Giovanni Lughezzani, Silvia Zandegiacomo, Roberto Peschechera, Arturo Chiti, Alberto Saita, Piergiuseppe Colombo, Giuliana Lista, Nicolò Maria Buffi, Alessio Benetti, Davide Maffei, Luisa Pasini, Luca Balzarini, Katia Marzo, Massimo Lazzeri, Angelo Castello, Egesta Lopci, Paolo Casale, Giorgio Guazzoni, Pasquale Cardone
Publikováno v:
Journal of Urology. 200:95-103
Purpose: 68Ga labeled prostate specific membrane antigen positron emission tomography/computerized tomography may represent the most promising imaging modality to identify and risk stratify prostate cancer in patients with contraindications to or neg
Autor:
Alessio Benetti, Arturo Chiti, Vittorio Fasulo, L. Domanico, Massimo Lazzeri, Luca Balzarini, Giovanni Lughezzani, G. Bevilacqua, Katia Marzo, Rodolfo Hurle, Alberto Saita, Lorenzo Leonardi, Paolo Casale, Angelo Castello, Egesta Lopci, Giorgio Guazzoni, Davide Maffei, Nicolò Maria Buffi, Marco Paciotti, Piergiuseppe Colombo
Publikováno v:
Journal of Urology. 201
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Katia Marzo
Publikováno v:
Clinical Applications of Nuclear Medicine Targeted Therapy ISBN: 9783319630663
Since the discovery of radium, the medical community has been interested in the application of unsealed radioactive isotopes to target and treat cancer and benign proliferative conditions. Radioactive iodine-131, as non radioactive Iodine, is taken u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97eec338b835e3c6fd739363e47b5d33
https://doi.org/10.1007/978-3-319-63067-0_2
https://doi.org/10.1007/978-3-319-63067-0_2
Publikováno v:
Physica Medica. 52:123-124
Purpose The aim of this study is to assess the typical doses associated with PET/CT examination in a large population and to evaluate the difference of effective dose estimation in fixed vs patient-adapted activity utilizing the same imaging protocol
319. Effective Dose Assessment on an Hybrid Equipment: Results and challenges to integrate with MDCT
Publikováno v:
Physica Medica. 56:257
Purpose The aim of this study was to measure, monitor and report effective dose in nuclear medicine and to assess current challenges in integrating these measures with CT. Methods In 2014 we connected a CT-PET to a dose tracking software and started
Publikováno v:
Physica Medica. 52:55
Purpose The aim of this study was to measure, monitor and report the effective dose in nuclear medicine on s large population and to integrate these measurements with CT dose data. Methods and materials A dose tracking software (GE Dosewatch™) with